161 related articles for article (PubMed ID: 37610445)
1. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
[TBL] [Abstract][Full Text] [Related]
2. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
[TBL] [Abstract][Full Text] [Related]
3. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
[TBL] [Abstract][Full Text] [Related]
4. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
[TBL] [Abstract][Full Text] [Related]
5. Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer.
Huang Z; Xing S; Zhu Y; Qu Y; Jiang L; Sheng J; Wang Q; Xu S; Xue N
Technol Cancer Res Treat; 2020; 19():1533033820971605. PubMed ID: 33191854
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection.
Chen S; Li X; Lv H; Wen X; Ding Q; Xue N; Su H; Chen H
Int J Biol Sci; 2018; 14(13):1813-1821. PubMed ID: 30443185
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery.
Feng J; Wang L; Yang X; Chen Q
Sci Rep; 2024 Jan; 14(1):713. PubMed ID: 38184747
[TBL] [Abstract][Full Text] [Related]
8. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer
Based on Geriatric Nutritional Risk Index].
Zhang X; Xiong Y; Xu A
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
[No Abstract] [Full Text] [Related]
11. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection.
Chen S; Lai Y; He Z; Li J; He X; Shen R; Ding Q; Chen H; Peng S; Liu W
J Transl Med; 2018 May; 16(1):116. PubMed ID: 29728103
[TBL] [Abstract][Full Text] [Related]
13. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
16. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
